Written by Taylor Woosley, Staff Writer. 12-week supplementation of 12 g of 6 non-essential amino acids (alanine, aspartic acid, glutamic acid, glycine, proline, and serine) resulted in improved VAS, JKOM, and JOA scores, suggesting that the treatment group experienced improved joint pain, discomfort, and stiffness both in a resting state and during normal activity.
Written by Taylor Woosley, Staff Writer. Study findings show that plasma vitamin C levels in two categories (suboptimal (≤8.8 mg/L) and sufficient (>8.8 mg/L)) were positively associated with BMD at the spine in men (p = 0.004). However, no association was noted in women (p = 0.552).
Written by Taylor Woosley, Staff Writer. Results of the dose-response meta-analysis including 17 RCTs show that resveratrol supplementation significantly decreased TC (p < 0.001), TG (p < 0.001), and LDL-C (p=0.038). Furthermore, results from the sub-group analysis show that a more significant reduction of LDL-C was observed in trials with a duration of ≥12 weeks.
Written by Chrystal Moulton, Staff Writer. The resveratrol group showed significant improvement in clinical attachment levels (CAL), bleeding index (BI), probing pocket depth (PPD), and oral hygiene index- simplified (OHI-S) compared to placebo [P < 0.01].
Written by Taylor Woosley, Staff Writer. Results of the 10-week randomized, double-blinded, placebo-controlled crossover trial show that WSTC increased the serum total antioxidant capacity levels (p<0.05), while attenuating platelet endogenous reactive oxygen species generation (p<0.05), and inhibiting platelet aggregation and activation (p<0.05).
Written by Taylor Woosley, Staff Writer. Findings of a systemic review and meta-analysis using 29 RCTs involving 2396 participants with 5 types of arthritis show that administration of curcumin and curcuma longa extract resulted in significant improvement in inflammatory markers and symptoms related to arthritis.
Written by Taylor Woosley, Staff Writer. 4-week supplementation of 150 mg/day of Pycnogenol significantly improved Visual Analogue Scale Line scores (P<0.05) and significantly decreased levels of oxidative stress (P<0.05). Furthermore, subjects in the Pycnogenol® group had a significant (>15%) increase in venoarteriolar response.
Written by Taylor Woosley, Staff Writer. After 18 weeks of treatment, P/C arms showed a significant decrease in CIPN severity (P < 0.01) and an increase in patient’s recovery/improvement (P < 0.01) compared to C/P arms in all related scales.
Written by Taylor Woosley, Staff Writer. Study analysis of 294970 subjects who participated in the UK Biobank shows that compared with those with 50 nmol/L, individuals with serum 25(OH)D concentration at 25 nmol/L have a 6.4% (95% CI, 3.85-8.98) higher serum CRP concentration.
Written by Taylor Woosley, Staff Writer. Analyzing individual changes in LTL from inclusion to 42 months shows a significant difference in change of LTL observed in the active treatment group vs. the placebo group (delta LTL, +0.019 vs. -0.129, p=0.02).
